TP53 and lung carcinoma: This is the case for SNORA42 in lung cancer [10], in which SNORA42 is overexpressed in non-small cell lung cancer and its suppression inhibits cell growth, proliferation and tumorigenicity of cancer cells by inducing p53-dependent apoptosis.